Injective Price Sees Renewed Strength After Coinbase Integration

Injective's native INJ token has seen renewed strength following its integration on Coinbase, one of the largest regulated cryptocurrency exchanges in the US. This update provides users with seamless deposits and withdrawals directly through the Injective blockchain, reducing friction for those moving assets into the ecosystem.

The integration is a significant step forward for Injective's broader growth strategy, as it increases exposure to millions of retail and institutional investors. Greater accessibility can lead to stronger ecosystem participation over time, particularly in decentralized finance activity across Layer-1 networks.

The Injective price has been building a constructive recovery after defending its long-term demand zone between $3.50 and $4.50. The next major obstacle sits between $7.70 and $8.00, where previous selling pressure created a significant supply zone. A decisive breakout above this region could invalidate the broader lower-high structure that defined INJ's correction over recent months.

The success of the Injective price extending gains will largely depend on buyers reclaiming the $8 resistance zone, where the current recovery faces its biggest technical challenge. A successful breakout would strengthen the bullish case for a broader trend reversal, while failure to clear this level could keep INJ consolidating before its next directional move.